[SCHEDULE 14A x Check the appropriate box: ¨ Preliminary Proxy Statement ¨ ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ JPMorgan China Region Fund, Inc. _______________________________________ Payment of Filing Fee (Check the appropriate box): x No fee required ¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11 (1) Title of each class of securities to]
[SCHEDULE 14A x Check the appropriate box: ¨ Preliminary Proxy Statement ¨ ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ JPMorgan China Region Fund, Inc. _______________________________________ Payment of Filing Fee (Check the appropriate box): x No fee required ¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11 (1) Title of each class of securities to]
[Registration No. 333-211545 SUMMARY OF FINAL TERMS June 9, 2016 $100,000,000 SEASPAN CORPORATION 8.20% SERIES G CUMULATIVE REDEEMABLE PERPETUAL PREFERRED SHARES This summary pricing sheet relates only to the securities described below and should only be read together with the Preliminary Prospectus Supplement, subject to completion, dated June 9, 2016, relating to these securities and supersedes the information in the]
[Registration No. 333-211545 SUMMARY OF FINAL TERMS June 9, 2016 $100,000,000 SEASPAN CORPORATION 8.20% SERIES G CUMULATIVE REDEEMABLE PERPETUAL PREFERRED SHARES This summary pricing sheet relates only to the securities described below and should only be read together with the Preliminary Prospectus Supplement, subject to completion, dated June 9, 2016, relating to these securities and supersedes the information in the]
[Seaspan Corporation nd Unit 2, 2 141 Connaught Road West Hong Kong, China c/o 2600 200 Granville Street Vancouver, BC Canada V6C 1S4 Tel: 604-638-2575 Fax: 604-648-9782 www.seaspancorp.com Seaspan Announces Pricing of $100 Million Public Offering of 8.20% Series G Cumulative Redeemable Perpetual Preferred Shares HONG KONG, CHINA, June 9, 2016 Seaspan Corporation (Seaspan) (NYSE:SSW) announced today that it] [Item 1 Information Contained in this Form 6-K Report SEASPAN CORPORATION David Spivak Chief Financial Officer (Principal Financial and Accounting Officer) 6-K 1 d204584d6k.htm FORM 6-K]
[Seaspan Corporation nd Unit 2, 2 141 Connaught Road West Hong Kong, China c/o 2600 200 Granville Street Vancouver, BC Canada V6C 1S4 Tel: 604-638-2575 Fax: 604-648-9782 www.seaspancorp.com Seaspan Announces Pricing of $100 Million Public Offering of 8.20% Series G Cumulative Redeemable Perpetual Preferred Shares HONG KONG, CHINA, June 9, 2016 Seaspan Corporation (Seaspan) (NYSE:SSW) announced today that it] [Item 1 Information Contained in this Form 6-K Report SEASPAN CORPORATION David Spivak Chief Financial Officer (Principal Financial and Accounting Officer) 6-K 1 d204584d6k.htm FORM 6-K]
[Seaspan Corporation nd Unit 2, 2 141 Connaught Road West Hong Kong, China c/o 2600 200 Granville Street Vancouver, BC Canada V6C 1S4 Tel: 604-638-2575 Fax: 604-648-9782 www.seaspancorp.com Seaspan Announces Public Offering of Series G Cumulative Redeemable Perpetual Preferred Shares RBC Capital Markets, J.P. Morgan, Stifel and Incapital will act as joint book-running managers for the offering. BB&T Capital] [Item 1 Information Contained in this Form 6-K Report SEASPAN CORPORATION David Spivak Chief Financial Officer (Principal Financial and Accounting Officer) 6-K 1 d205502d6k.htm FORM 6-K]
[Seaspan Corporation nd Unit 2, 2 141 Connaught Road West Hong Kong, China c/o 2600 200 Granville Street Vancouver, BC Canada V6C 1S4 Tel: 604-638-2575 Fax: 604-648-9782 www.seaspancorp.com Seaspan Announces Public Offering of Series G Cumulative Redeemable Perpetual Preferred Shares RBC Capital Markets, J.P. Morgan, Stifel and Incapital will act as joint book-running managers for the offering. BB&T Capital] [Item 1 Information Contained in this Form 6-K Report SEASPAN CORPORATION David Spivak Chief Financial Officer (Principal Financial and Accounting Officer) 6-K 1 d205502d6k.htm FORM 6-K]
[This document is in two parts. The first part is the prospectus supplement, which describes the specific terms of this offering. The second part is the accompanying base prospectus, which gives more general information, some of which may not apply to this offering. Generally, when we refer to the prospectus, we are referring to both parts combined. If information in]
[CUSIP No. 16938C106 1. Names of reporting persons. WP X Biologics LLC 2. Check the appropriate box if a member of a group (see instructions). ¨ x (a) 3. SEC use only 4. Source of funds (see instructions) N/A 5. ¨]
